An economic model developed by Dr. Jayson Lusk, dean and vice president of the Division of Agricultural Sciences and Natural Resources at Oklahoma State University, paints a compelling picture: adopting PRRS-resistant pigs offers meaningful benefits with minimal trade-offs.
In April 2025, PIC was granted approval by the FDA for the gene edit used in its PRRS-resistant pig, an extraordinary step forward in eliminating challenges from one of the most serious global pig diseases.